About us

A European Reference Network (ERN) is a virtual network comprised of healthcare professionals spread around Europe. Their objective is to tackle complex or rare diseases and conditions that necessitate highly specialised treatment and a concentration of knowledge and resources. Indeed, often a disease is so rare that expert knowledge is not available in the patient’s country or region and ERNs facilitate the exchange of knowledge between healthcare professionals across borders. Each ERN has a coordinator who convenes “virtual” advisory boards of medical specialists across different disciplines, using a dedicated IT platform and telemedicine tools to review a patient’s condition for diagnosis and treatment. The patient doesn’t travel but knowledge does.

The first 24 ERNs were launched in 2017, involving more than 900 highly-specialised healthcare units from over 300 hospitals in 26 Member States. Please find the press release from the European Commission here , their ERN Fact Sheet here and the ERN Brochure here.

For more information about ERNs, please visit the European Commission’s webpages.

Cross-Border Healthcare

One of the key objectives of the ERN is to provide cross-border healthcare which means that as a patient you can access expert healthcare services in another EU country, which is not your home country.  According to the European Commission, "EU citizens have the right to access healthcare in any EU country and to be reimbursed for care abroad by their home country".

Information about national contact points, health insurance institutions and healthcare providers can also be found on the European Commission's website.

What is ERN-RND?

The European Reference Network for Rare Neurological Diseases (ERN- RND) aims to address the unmet needs of more than 500,000 people living with RNDs in Europe. 60% of those are still undiagnosed. Through coordination and knowledge transfer, ERN-RND shall establish a patient-centred network to address the needs of patients with RND of all age groups, with or without a definite diagnosis, by implementing an infrastructure for diagnosis, evidence-based management, treatment and collection of patient data.

Objectives of ERN-RND

  • To significantly increase the overall percentage of RND patients with a final diagnosis
  • To improve and harmonise care of RND patients across the EU
  • To develop, share and implement care pathways and guidelines for all RND groups represented in ERN-RND
  • To create, develop and enhance constituents’ capacity to design, implement and supervise RND training, education and capacity building measures at the level of member states and of the network
  • To develop a comprehensive and data based European RND cohort to better understand these conditions and thus improve their management and help developing and testing treatments
  • To define minimum quality and interoperability criteria for RND registries


Disease groups covered

ERN-RND will expand over time in terms of the diseases it covers and in terms of EU countries involved.

These 6 Disease Groups (DGs) gather the respective experts from all ERN-RND member hospitals. They work on DG specific topics such as care standards, specific dissemination of disease knowledge, etc.
Each DG is lead by several coordinators.
Their work is available in the Disease Knowledge documents which can be found in the Disease Knowledge section of the website.

Back to the top

ERN-RND coordinators

Holm Graessner

Coordinator ERN-RND
Institute of Medical Genetic & Applied Genomics
University Hospital Tübingen

Ludger Schöls

Clinical Coordinator ERN-RND
Department of Neurology
University Hospital Tübingen

ERN-RND coordination office

Carola Reinhard

Project manager

Sophie Ripp

Project manager

Christine Diaite-Hecht

Training manager

Tamara Martin

CPMS Helpdesk

Aikaterini Filippidou

Communication manager

Lena Urbanczyk

Support for administrative project management


The ERN-RND Board is the main decision taking body of ERN-RND. The board sets the strategy for the network. The board is chaired by the network co-ordinator. The membership of the board includes the individual HCP leads (or their nominated deputies). The board meets twice a year.

Patient Advocates

EURORDIS, the European umbrella organisation of patient organisations and a non-profit alliance of 798 rare disease patient organisations, has established a European Patient Advocacy Group (ePAG) for each ERN disease grouping. Patient organisations can become ePAG member organisations and patients can become ePAG representatives (2016 and onwards).
You can find the Annex to the ERN-RND Network Agreement regarding the rules for the patient advocacy group here.
Information on 'Thinking of getting involved in the ERNs as an ePAG advocate' here and the Patient Partnership Framework for ERNs here. More detailed information on European Reference Networks and European Advocacy Patient Groups here and here.

Astri Arnesen

European Huntington Association
Representative for: Choreas & Huntington's Disease
Email: astri[at]eurohuntington.org

Foto: Stephan Röhl

Monika Benson

Dystonia Europe
Representative for: Dystonia
Email: monika.benson[at]dystonia-europe.org

Mary Kearney

Lori Renna Linton

Representative for: Ataxia/HSP
Email: lori.rennalinton[at]gmail.com

Lubomír Mazouch

Czech Association of Atypical Parkinsonian Syndromes (Spolek pro Atypické parkinsonské syndromy)
Representative for: Atypical Parkinsonian Syndromes
Email: SpolekproAPS[at]seznam.cz

Natalia Grigorova

Bulgarian Huntington Association
Representative for: Choreas & Huntington's Disease
Email: info[at]huntington.bg

Sara Hunt

Alex, The Leukodystrophy Charity
Representative for: DG Leukodystrophies
Email: Sara[at]alextlc.org

Juliane Krabath

STOPP-HSP, Austria
Representative for: DG Ataxia/HSP
Email: juliane.krabath[at]gmail.com

John Gerbild

Denmark Association for Ataxia and HSP
Representative for: Ataxia/HSP
Email: john[at]sca-hsp.dk

Work Packages

Activities of the ERN-RND are structured in eight dedicated Work Packages (WP):

WP Title
1 Coordination
2 Dissemination
3 Evaluation
4 CPMS activities
5 Other digital activities of ERN-RND (ERN-RND registry)
6 Training and education
7 Guidelines, Clinical Decision Making Tools and Patient Journeys
8 Care access and quality


European Reference Networks are being monitored according to 18 indicators, please find the the full document here and ERN-RND Monitoring Data of 2021 here.

Publications acknowledging ERN-RND